Position in ORGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,018,599
+$1,572,402 QoQ
Shares Held
2,888,313
+25.7% QoQ
Ownership
2.24%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 134 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. ORGO ranks #21 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in ORGO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,018,599 | 2,888,313 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,446,197 | 2,297,974 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,300,320 | 1,988,479 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,159,103 | 511,636 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,243,795 | 613,059 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,820,123 | 884,288 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,359,816 | 737,443 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,111,008 | 738,115 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,077,411 | 741,933 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,796,992 | 632,744 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,954,505 | 966,872 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,454,172 | 1,086,218 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,219,603 | 1,270,965 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,855,995 | 1,340,843 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,161,649 | 431,840 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $631,080 | 194,778 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $738,124 | 151,255 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $485,889 | 63,765 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $706,906 | 76,505 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,898,433 | 133,317 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $741,152 | 44,594 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||